Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Moodys
Dow
Medtronic
McKesson

Last Updated: January 26, 2023

CLINICAL TRIALS PROFILE FOR VARENICLINE TARTRATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Varenicline Tartrate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00141167 ↗ A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo for Smoking Cessation Completed Pfizer Phase 3 2005-02-01 The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo for smoking cessation.
NCT00141206 ↗ A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation Completed Pfizer Phase 3 2003-05-01 The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo and Zyban for smoking cessation.
NCT00143299 ↗ A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline Completed Pfizer Phase 3 2003-10-01 The primary purpose of this study is to obtain safety information on cigarette smokers treated with 52 weeks of varenicline regardless of smoking status.
NCT00143325 ↗ An Open Label Study That Compares Varenicline to Transdermal Nicotine Patch for Smoking Cessation Completed Pfizer Phase 3 2005-01-01 Open-label comparison of standard 12-week regimen of varenicline with standard 10-week regimen of transdermal nicotine patch for smoking cessation.
NCT00143364 ↗ A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation Completed Pfizer Phase 3 2003-06-01 The primary purpose of this study is to evaluate the safety and efficacy of varenicline given for a twelve week treatment period in comparison with placebo and Zyban for smoking cessation.
NCT00282984 ↗ Efficacy and Safety of Varenicline in Smokers With Cardiovascular Disease Who Wish to Quit Smoking Completed Pfizer Phase 3 2006-02-01 The primary purpose of this study is to determine whether or not varenicline will help people with cardiovascular disease quit smoking and to confirm it is safe in these patients.
NCT00285012 ↗ Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD). Completed Pfizer Phase 3 2006-05-01 This study is to be conducted in subjects with mild-to-moderate COPD who are cigarette smokers with the intent of demonstrating differences in smoking cessation between varenicline and placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Varenicline Tartrate

Condition Name

Condition Name for Varenicline Tartrate
Intervention Trials
Smoking Cessation 24
Smoking 3
Tobacco Dependence 2
Schizophrenia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Varenicline Tartrate
Intervention Trials
Tobacco Use Disorder 4
Schizophrenia 3
Problem Behavior 2
Mental Disorders 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Varenicline Tartrate

Trials by Country

Trials by Country for Varenicline Tartrate
Location Trials
United States 169
South Africa 21
Canada 16
Mexico 16
Brazil 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Varenicline Tartrate
Location Trials
Massachusetts 11
California 10
Pennsylvania 9
New York 8
Connecticut 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Varenicline Tartrate

Clinical Trial Phase

Clinical Trial Phase for Varenicline Tartrate
Clinical Trial Phase Trials
Phase 4 10
Phase 3 10
Phase 2/Phase 3 3
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Varenicline Tartrate
Clinical Trial Phase Trials
Completed 33
Active, not recruiting 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Varenicline Tartrate

Sponsor Name

Sponsor Name for Varenicline Tartrate
Sponsor Trials
Pfizer 25
Mayo Clinic 2
Lapland Central Hospital Rovaniemi Finland 1
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Varenicline Tartrate
Sponsor Trials
Industry 28
Other 15
NIH 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
McKesson
Colorcon
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.